<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05105594</url>
  </required_header>
  <id_info>
    <org_study_id>CSP1</org_study_id>
    <nct_id>NCT05105594</nct_id>
  </id_info>
  <brief_title>Causes of Kinesiophobia in Lymphedema</brief_title>
  <official_title>Investigation of Causes of Kinesiophobia, Fatigue and Quality of Life in Patients With Lower Extremity Lymphedema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara City Hospital Bilkent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara City Hospital Bilkent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the reason for the fear of movement in patients with lymphedema will be&#xD;
      investigated and recommendations will be given to the patients to eliminate it.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">November 15, 2021</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Kinesiophopia Causes Scale</measure>
    <time_frame>10 minutes</time_frame>
    <description>It is a 20 question survey. A higher score on the questionnaire indicates that they have more fear of movement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>functional assessment of chronic illness therapy</measure>
    <time_frame>10 minutes</time_frame>
    <description>It consists of 13 questions assessing the level of fatigue during daily activities in the last 7 days.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lymphedema Quality of Life Questionnaire</measure>
    <time_frame>10 minutes</time_frame>
    <description>It is a survey consisting of 21 questions. High scores indicate lower quality of life.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Lymphedema</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>People who have lymphedema</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>healty people</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>survey application</intervention_name>
    <description>Fear of movement will be evaluated with the Kinesiophopia Causes Scale. It is a 20-question survey in which the causes of fear of movement are investigated. Functional Evaluation of Treatment of Fatigue Chronic Disease will be assessed by the Fatigue Questionnaire. It consists of 13 questions assessing the level of fatigue during daily activities in the last 7 days. Quality of Life will be assessed by the Lymphedema Quality of Life Questionnaire.</description>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <other_name>Lymphedema Group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Those between the ages of 18-65&#xD;
&#xD;
          -  To be diagnosed with lymphedema in the unilateral lower extremity&#xD;
&#xD;
          -  Volunteering to work&#xD;
&#xD;
          -  Not having orthopedic disorders in the lower extremities&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not volunteering to participate in the research&#xD;
&#xD;
          -  Having bilateral lower extremity lymphedema&#xD;
&#xD;
          -  Having an active infection&#xD;
&#xD;
          -  Having a mental cognitive disorder&#xD;
&#xD;
          -  Being unable to communicate and cooperate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ankara City Hospital</name>
      <address>
        <city>Ankara</city>
        <state>Ã‡ankaya</state>
        <zip>06800</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 26, 2021</study_first_submitted>
  <study_first_submitted_qc>October 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara City Hospital Bilkent</investigator_affiliation>
    <investigator_full_name>Cansu Sahbaz Pirincci</investigator_full_name>
    <investigator_title>Phd</investigator_title>
  </responsible_party>
  <keyword>lymphedema, Kinesiophobia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphedema</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

